Insider selling: ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Baity Glenn; EVP AND GC sold 26507 shares
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) finished the trading with positive move of +1.54% and closed the day at $36.16 which had been above its previous day’s closing of $35.61.
Shares of the company registered a buying and selling volume of 1.4 million shares lower than its 3-months average volume of 1.45 million shares and traded in range of $35.13 to $36.57.
The firm has price to sales ratio of 69.20 and its price to book per share was 10.50. The stock is trading higher its 50-day moving averages of 31.14 and above 200-day moving averages of 31.78. The shares registered one year high of $40.83 and one year low was seen at $20.68.
Recent Insider Activity:
Currently the Insiders own 0.10% of ACADIA Pharmaceuticals Inc. shares. Institutional Investors own 99.20% of company’s shares. During last three month period, the net percent change held by Institutional Investors has seen a change of 0.28%. During last six month period, the net percent change kept by insiders has seen a change of -40.38%.
In the company’s insider trading activities, Baity Glenn; EVP AND GC of ACADIA Pharmaceuticals Inc. sold 26507 shares worth of $924315 in a transaction on 30 Aug 2017. In this transaction, these shares were sold at value of $34.87 per share, according to the information disclosed by the Securities and Exchange Commission in a Form 4 filing on 01 Sep 2017.
Baity Glenn; also sold 14322 shares worth of $499534 in a transaction dated on 09 Aug 2017. Shares were sold at the average price of 34.88 per share, according to SEC Form 4 filing submitted on 11 Aug 2017.